KR880002376B1 - 카르복시 알켄아미도 세팔로스포린의 제조방법 - Google Patents

카르복시 알켄아미도 세팔로스포린의 제조방법 Download PDF

Info

Publication number
KR880002376B1
KR880002376B1 KR1019840006134A KR840006134A KR880002376B1 KR 880002376 B1 KR880002376 B1 KR 880002376B1 KR 1019840006134 A KR1019840006134 A KR 1019840006134A KR 840006134 A KR840006134 A KR 840006134A KR 880002376 B1 KR880002376 B1 KR 880002376B1
Authority
KR
South Korea
Prior art keywords
methyl
hydrogen
mixture
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019840006134A
Other languages
English (en)
Korean (ko)
Other versions
KR850002989A (ko
Inventor
요시오 하마시마
Original Assignee
시오노기 세이야꾸 가부시끼가이샤
요시또시 가즈오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58186601A external-priority patent/JPS6078987A/ja
Priority claimed from JP59018563A external-priority patent/JPS60163884A/ja
Priority claimed from JP59100890A external-priority patent/JPH0780892B2/ja
Application filed by 시오노기 세이야꾸 가부시끼가이샤, 요시또시 가즈오 filed Critical 시오노기 세이야꾸 가부시끼가이샤
Publication of KR850002989A publication Critical patent/KR850002989A/ko
Priority to KR1019880012223A priority Critical patent/KR880002684B1/ko
Application granted granted Critical
Publication of KR880002376B1 publication Critical patent/KR880002376B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019840006134A 1983-10-04 1984-10-04 카르복시 알켄아미도 세팔로스포린의 제조방법 Expired KR880002376B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019880012223A KR880002684B1 (ko) 1983-10-04 1988-09-21 카르복시알켄산 및 그의 유도체의 제조방법

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP186601 1983-10-04
JP186601/83 1983-10-04
JP58186601A JPS6078987A (ja) 1983-10-04 1983-10-04 アクリルアミドセフアロスポリン類
JP18563 1984-02-03
JP18563/84 1984-02-03
JP59018563A JPS60163884A (ja) 1984-02-03 1984-02-03 カルボキシアルケンアミドセフアロスポリン
JP100890/84 1984-05-18
JP100890 1984-05-18
JP59100890A JPH0780892B2 (ja) 1984-05-18 1984-05-18 カルボキシアルケンアミドセフアロスポリン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012223A Division KR880002684B1 (ko) 1983-10-04 1988-09-21 카르복시알켄산 및 그의 유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR850002989A KR850002989A (ko) 1985-05-28
KR880002376B1 true KR880002376B1 (ko) 1988-11-03

Family

ID=27282263

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019840006134A Expired KR880002376B1 (ko) 1983-10-04 1984-10-04 카르복시 알켄아미도 세팔로스포린의 제조방법
KR1019880012223A Expired KR880002684B1 (ko) 1983-10-04 1988-09-21 카르복시알켄산 및 그의 유도체의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019880012223A Expired KR880002684B1 (ko) 1983-10-04 1988-09-21 카르복시알켄산 및 그의 유도체의 제조방법

Country Status (22)

Country Link
US (3) US4634697A (https=)
EP (1) EP0136721B1 (https=)
KR (2) KR880002376B1 (https=)
AR (1) AR242392A1 (https=)
AT (1) ATE99311T1 (https=)
AU (2) AU575854B2 (https=)
CA (2) CA1238910A (https=)
DE (2) DE136721T1 (https=)
DK (1) DK171043B1 (https=)
ES (3) ES8604602A1 (https=)
FI (1) FI82057C (https=)
GB (3) GB2154580B (https=)
GR (1) GR80544B (https=)
HU (1) HU193298B (https=)
IE (1) IE57744B1 (https=)
IL (3) IL84653A (https=)
MX (1) MX174328B (https=)
NL (1) NL940013I2 (https=)
NO (2) NO173238C (https=)
NZ (2) NZ218741A (https=)
PH (2) PH20223A (https=)
PT (1) PT79287A (https=)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
JP2501785B2 (ja) * 1984-07-09 1996-05-29 明治製菓株式会社 新規セフアロスポリン系化合物
JPS6124580A (ja) * 1984-07-12 1986-02-03 Shionogi & Co Ltd アミノチアゾリルグルタル酸誘導体の製造方法
JPS6153272A (ja) * 1984-08-24 1986-03-17 Shionogi & Co Ltd グルタル酸誘導体の製法
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters
DE3677253D1 (de) 1985-04-30 1991-03-07 Lilly Co Eli 7-substituierte bicyclische pyrazolidinone.
US4731362A (en) * 1985-08-05 1988-03-15 Shionogi & Co., Ltd. Alkylcarbamoyloxymethylcephem compounds
AT396652B (de) * 1986-07-02 1993-11-25 Shionogi & Co Verfahren zur herstellung von hartgelatinekapsel-zusammensetzungen
US5017380A (en) * 1986-07-02 1991-05-21 Shionogi & Co., Ltd. Gelatin hard capsule containing crystalline hydrate of oral cephalosporin
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
DE3745094B4 (de) * 1986-07-02 2004-12-30 Shionogi & Co., Ltd. Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
US5079242A (en) * 1987-03-11 1992-01-07 Pfizer Inc. Substituted 3-cephem compounds as antibacterial agents
US5242913A (en) * 1987-03-11 1993-09-07 Pfizer Inc. Substituted 3-cephem compounds as antibacterial agents
US4820832A (en) * 1988-03-23 1989-04-11 Eli Lilly And Company Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
US5245027A (en) * 1989-11-21 1993-09-14 Bristol-Myers Squibb Company 3-fluorosulfonyloxyceph-3-em compounds
US5612048A (en) * 1994-11-22 1997-03-18 Amvac Chemical Corporation Stabilized moisture-sensitive pesticide composition and method of making
US5571910A (en) * 1994-12-09 1996-11-05 Schering Corporation Process for the preparation of intermediates useful in the synthesis of cephalosporins
JPH101482A (ja) * 1996-06-13 1998-01-06 Otsuka Chem Co Ltd ３−ノルセフェム化合物の製造法
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US8225458B1 (en) 2001-07-13 2012-07-24 Hoffberg Steven M Intelligent door restraint
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20050152852A1 (en) * 2002-05-27 2005-07-14 Morinaga & Co., Ltd. Use of antibacterial component extracted from cacao mass for inhibiting the growth of periodontal bacteria
WO2005009365A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8758820B2 (en) * 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
JP2007502294A (ja) * 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8246996B2 (en) * 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2007513869A (ja) * 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2081922B1 (en) 2006-12-22 2012-02-01 Schering Corporation 5,6-Ring annulated indole derivatives and use thereof
JP5211068B2 (ja) * 2006-12-22 2013-06-12 メルク・シャープ・アンド・ドーム・コーポレーション Ｈｃｖおよび関連するウイルス疾患の治療または予防のための４，５−環インドール誘導体
AU2007339382B2 (en) 2006-12-22 2013-05-02 Merck Sharp & Dohme Llc 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
ATE541845T1 (de) * 2007-08-29 2012-02-15 Schering Corp 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
WO2009032116A1 (en) * 2007-08-29 2009-03-12 Schering Corporation 2, 3-substituted indole derivatives for treating viral infections
TW200924780A (en) * 2007-08-29 2009-06-16 Schering Corp 2-carboxy substituted indole derivatives and methods of use thereof
CA2705587A1 (en) * 2007-11-16 2009-05-22 Schering Corporation 3-aminosulfonyl substituted indole derivatives and methods of use thereof
MX2010005356A (es) * 2007-11-16 2010-05-27 Schering Corp Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
AR072088A1 (es) * 2008-06-13 2010-08-04 Schering Corp Derivados de indol triciclicos y sus metodos de uso
JP5619743B2 (ja) 2008-08-20 2014-11-05 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． エテニル置換ピリジンおよびピリミジン誘導体およびウイルス感染の治療におけるそれらの使用
TWI409265B (zh) 2008-08-20 2013-09-21 Merck Sharp & Dohme 經取代之吡啶及嘧啶衍生物及彼等於治療病毒感染之用途
TW201020245A (en) 2008-08-20 2010-06-01 Schering Corp Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8470834B2 (en) 2008-08-20 2013-06-25 Merck Sharp & Dohme Corp. AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2763140A1 (en) 2009-05-29 2010-12-02 Schering Corporation Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
JP2013512246A (ja) 2009-11-25 2013-04-11 メルク・シャープ・アンド・ドーム・コーポレーション ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
US20130156731A1 (en) 2009-12-22 2013-06-20 Kevin X. Chen Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
EP2536410B1 (en) 2010-02-18 2015-09-23 Merck Sharp & Dohme Corp. Substituted pyrimidine derivatives and their use in treating viral infections
EA201290882A1 (ru) 2010-03-09 2013-04-30 Мерк Шарп Энд Домэ Корп. Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
CN101824004B (zh) * 2010-04-30 2012-02-22 黄山市歙县宏辉化工有限公司 一种头孢布烯侧链的合成工艺
EP2566449B1 (en) 2010-05-04 2014-10-08 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
WO2012018534A2 (en) 2010-07-26 2012-02-09 Schering Corporation Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2013540122A (ja) 2010-09-29 2013-10-31 メルク・シャープ・エンド・ドーム・コーポレイション 縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
WO2012142075A1 (en) 2011-04-13 2012-10-18 Merck Sharp & Dohme Corp. 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
BR112013026345A2 (pt) 2011-04-13 2019-04-24 Merck Sharp & Dohe Corp. composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
US20140378416A1 (en) 2011-09-14 2014-12-25 Michael P. Dwyer Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
WO2013109225A1 (en) 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical tablet formulations comprising ceftibuten
WO2013151518A1 (en) 2012-04-04 2013-10-10 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (en) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
WO2015065817A1 (en) 2013-10-30 2015-05-07 Merck Sharp & Dohme Corp. Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
EP3031450A1 (en) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten capsule compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB149039A (en) * 1919-04-30 1920-07-30 Lawrence Ennis Improvements in or relating to steel framed cottages
GB966131A (en) * 1959-04-07 1964-08-06 Union Carbide Corp Process for the preparation of organic compounds
US3994888A (en) * 1973-06-18 1976-11-30 Eli Lilly And Company Cephalosporin cleavage process
GB1497039A (en) * 1973-12-05 1978-01-05 Glaxo Lab Ltd Penicillins and cephalosporins
US4263212A (en) * 1979-02-28 1981-04-21 Rikagaku Kenkyusho Process for preparation of substituted olefins
GB2076801A (en) * 1980-04-14 1981-12-09 Erba Farmitalia alpha , beta -Disubstituted Acrylamido Cephalosporins
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3145727A1 (de) * 1981-11-19 1983-05-26 Bayer Ag, 5090 Leverkusen Zwischenprodukte, verfahren zu deren herstellung und verfahren zur herstellung von cephalosporinen
CA1201431A (en) * 1981-12-17 1986-03-04 Daiei Tunemoto .beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF
DE3224866A1 (de) * 1982-07-02 1984-01-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3300593A1 (de) * 1983-01-11 1984-07-12 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins

Also Published As

Publication number Publication date
NO176567B (no) 1995-01-16
GB2154580A (en) 1985-09-11
NO853806L (no) 1985-04-09
ATE99311T1 (de) 1994-01-15
IL84653A0 (en) 1988-04-29
GB2154580B (en) 1988-08-17
US4912224A (en) 1990-03-27
HUT36129A (en) 1985-08-28
DK171043B1 (da) 1996-04-29
FI843871L (fi) 1985-04-05
GB2190914A (en) 1987-12-02
NL940013I1 (nl) 1994-08-16
NO173238B (no) 1993-08-09
IL73159A0 (en) 1985-01-31
EP0136721A3 (en) 1986-01-22
GB8700123D0 (en) 1987-02-11
ES547300A0 (es) 1986-11-16
NO843956L (no) 1985-04-09
NZ209634A (en) 1988-07-28
IL73159A (en) 1990-08-31
EP0136721B1 (en) 1993-12-29
GB2198727A (en) 1988-06-22
AU575854B2 (en) 1988-08-11
MX174328B (es) 1994-05-09
GB8726623D0 (en) 1987-12-16
ES8700222A1 (es) 1986-11-16
PH21766A (en) 1988-02-18
KR880002684B1 (ko) 1988-12-20
GB2190914B (en) 1988-08-17
DE136721T1 (de) 1985-08-29
IE57744B1 (en) 1993-03-24
HU193298B (en) 1987-09-28
ES547301A0 (es) 1986-03-16
AR242392A1 (es) 1993-03-31
PH20223A (en) 1986-10-23
IE842524L (en) 1985-04-04
IL84653A (en) 1990-08-31
GB8424923D0 (en) 1984-11-07
NO176567C (no) 1995-04-26
CA1272713A (en) 1990-08-14
AU601842B2 (en) 1990-09-20
DE3486259D1 (de) 1994-02-10
EP0136721A2 (en) 1985-04-10
FI82057C (fi) 1991-01-10
DK474584A (da) 1985-04-05
AU3330084A (en) 1985-05-09
GB2198727B (en) 1988-11-16
US4748170A (en) 1988-05-31
US4634697A (en) 1987-01-06
CA1238910A (en) 1988-07-05
CA1272713C (https=) 1990-08-14
FI82057B (fi) 1990-09-28
DK474584D0 (da) 1984-10-03
GR80544B (en) 1985-02-05
DE3486259T2 (de) 1994-07-21
PT79287A (en) 1984-11-01
AU1619488A (en) 1988-08-11
ES8604602A1 (es) 1986-02-01
NO173238C (no) 1993-11-17
FI843871A0 (fi) 1984-10-02
NL940013I2 (nl) 1999-06-01
NZ218741A (en) 1988-07-28
ES8605278A1 (es) 1986-03-16
ES536502A0 (es) 1986-02-01
KR850002989A (ko) 1985-05-28

Similar Documents

Publication Publication Date Title
KR880002376B1 (ko) 카르복시 알켄아미도 세팔로스포린의 제조방법
KR0158452B1 (ko) 피페라지니오 세팔로스포린
NO782866L (no) Fremgangsmaate for fremstilling av cefalosporinderivater
JP2618119B2 (ja) チオアルキルチオセファロスポリン誘導体
US4254119A (en) 3-Unsubstituted-3-cephem compounds
KR920008953B1 (ko) 항균 화합물의 제조방법
NO852294L (no) Fremgangsmaate for fremstilling av antibakterielt virksomme cefemforbindelser.
KR930004015B1 (ko) 알킬카르바모일옥시메틸세펨 화합물의 제조방법
KR890000095B1 (ko) 플루오로메틸티오옥사세팔토스포린의 제조방법
US4731361A (en) Alkeneamidocephalosporin esters
KR900008552B1 (ko) 비닐티오 아세트아미도 옥사세팔로스포린 유도체의 제조방법
US5134138A (en) Phenacylpyridiniothiocephalosporins
Kakeya et al. KY-109, A NEW BIFUNCTIONAL PRO-DRUG OF A CEPHALOSPORIN CHEMISTRY, PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES
KR920004837B1 (ko) 세펨화합물의 제조방법
KR930007814B1 (ko) 세팔로스포린 유도체의 제조방법
US4683227A (en) Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof
JP2567799B2 (ja) カルボキシアルケン酸及びその誘導体
CS268513B2 (en) Method of 7 beta-(carboxyalkanolamino)-3-cefem-carboxyl acids production
KR810000806B1 (ko) 할로아릴말론아미도옥사세팔로스포린유도체의 제조방법
KR920004836B1 (ko) 항균 화합물의 제조방법
DD232049A5 (de) Verfahren zur herstellung von carboxyalkenamidocephalosporinen
KR910008351B1 (ko) 카르복시알켄아미도세팔로스포린 에스테르의 제조방법
KR890002229B1 (ko) 1-옥사데티아 세팔로스포린 화합물의 제조 방법
EP0300423A2 (en) Cephalosporin compound, method of its production and composition for prevention and treatment of bacterial infectious diseases
JPS60163884A (ja) カルボキシアルケンアミドセフアロスポリン

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19841004

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19871202

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19841004

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19880622

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19880930

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19890116

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19890201

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19890201

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19910604

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19920713

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19931008

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19940701

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19950623

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19960710

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19970818

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19971226

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19990608

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20000907

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20010919

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20020930

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20031022

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20031022

Start annual number: 16

End annual number: 16

EXPY Expiration of term
PC1801 Expiration of term